Nobel Biocare is about you, for your patient. That’s our promise. And it’s a promise based on over 65 years of research and development in implantology, ever since Per-Ingvar Brånemark’s groundbreaking discovery of osseointegration, and first ever dental implant treatment.
But we never settle for the status quo. We follow no one. We are bold innovators to the very core, doing whatever it takes to improve the possibilities for professionals to treat more patients better.
Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. Our goal is to empower dental professionals to give quality of life back to their patients.
This philosophy is built on over 65 years of continuous innovation, all stemming from Per-Ingvar Brånemark’s ground-breaking discovery of osseointegration in 1952. Since then, we’ve helped our customers treat millions of patients with our science-backed and forward-looking solutions.
Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials. The company is headquartered in Zurich, Switzerland. Production takes place at four sites located in the United States, Sweden and Japan. Products and services are available in over 80 countries through subsidiaries and distributors.
Our company’s portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including key brands NobelActive and NobelParallel and ceramic implant NobelPearl*) a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (NobelProcera), digital solutions for treatment planning and guided surgery (NobelClinician and DTX Studio suite) as well as biomaterials.
Professor Per-Ingvar Brånemark (right) with his first implant patient Gösta Larsson (left).
In implant dentistry, our heritage is truly unique. A philosophy of innovation, driven by patient need. A company inspired and led – to this day – by dental professionals who began their own journeys in practices and laboratories.
This all stems from Per-Ingvar Brånemark’s groundbreaking discovery of osseointegration. The sequence of companies that grew after he treated the very first patient, culminated in Nobel Biocare.
What we do
Everything that we do aims to empower you to treat more patients better. How do we ensure this? By concentrating on three key pillars.